Global Oncology/Cancer Drugs Market Is Up To Mark And Still In Process Of Developing

1
Global Oncology/Cancer Drugs Market
Published on 01 February, 2015 Number of
pages 105 Single User Price 4740
Global Oncology/Cancer Drugs Market Market by
Manufacturers, Regions, Type and Application,
Forecast to 2021
Click Here To Check Complete Report
2
Biological drugs based on monoclonal antibodies
(mAbs) have emerged as a preferred option for
treating various cancer types, especially for
blood cancer (leukemia). Rising incidence of
various cancer conditions, growing popularity of
advance therapies (biological and targeted drug
therapies), patents expiration of leading drugs
along with commercialization of biosimilars are
the few factors driving the growth of global
oncology drugs market. However, high cost
involved in new drug development coupled with
threat of failure and adverse effects associated
with cancer drugs therapies would restrain the
growth of the market. Commercialization of
advanced therapeutics such as targeted and
immunotherapies would reduce the negative
influence of restraints and fuel the market
growth.The global oncology drugs market is
expected to reach at 111.9 billion by 2020.
Patent expiration of key cancer drugs such as
Herceptin, Erbitux, Rituxan and Avastin, is
expected to boost the growth of cancer
biosimilars market by 2020. 
Avail more information from Sample Brochure of
report
3
Going further, the biological therapies are
expected to dominate the market by 2020, due to
their high efficacy, target specific action and
less toxicity. Blood cancer drugs market was the
largest revenue generating segment in 2013 owing
to the high cost of drugs (immunotherapies) used
for the treatment of blood cancer.Geographically,
North America, dominates the market followed by
Europe. North America accounted for about 38
share in the overall oncology drugs market in
2013 owing to the heavy investments by
multinational companies in research and
development of cancer drugs, particularly immune
therapeutics, favorable reimbursement policies,
and high adoption rate of immunotherapies. n the
other hand, Asia-Pacific market would grow at the
promising CAGR of 8.7 during the forecast
period. Such high growth rate is majorly due to
increasing awareness towards advanced therapies
namely immunotherapies and increase in per capita
healthcare spending.Key companies profiled in the
report are Roche diagnostics, Novartis AG,
Celgene Corporation, AstraZeneca, Johnson
Johnson, Merck Co., Eli Lilly Co.
4
and GlaxoSmithKline. Companies operating in the
cancer drugs market focus on several strategies
such as collaboration, approval and
acquisition.KEY BENEFITSThe report provides the
quantitative analysis of the current market and
estimations through 2013-2020 that assists in
identifying the prevailing market opportunities
to capitalize onThe report helps in understanding
the strategies adopted by various companies for
gaining market share in the cancer drugs
marketThe report provides comprehensive analysis
of factors that drive and restrict the growth of
the cancer drugs marketMarket conditions of
cancer drugs market across all geographic regions
are comprehensively analyzedCompetitive
intelligence (of leading manufacturers) helps in
understanding the competitive scenario across the
geographiesSWOT
5
analysis of the key market players is provided to
illustrate the business strategies adopted by the
companiesMARKET SEGMENTATIONThe cancer drugs
market is segmented by the therapeutic
modalities, cancer types and geography.MARKET BY
THERAPEUTIC MODALITIESChemotherapyTargeted
TherapyImmunotherapy (Biologic Therapy)Hormonal
TherapyOthersMARKET BY CANCER TYPESBlood
CancerBreast CancerGastrointestinal
CancerProstate CancerRespiratory/Lung CancerSkin
CancerOther CancersMARKET BY GEOGRAPHYNorth
AmericaUnited StatesCanadaMexicoEuropeGermanyFranc
eUnited KingdomOthersAsia-PacificIndiaChinaJapanAu
straliaOthersLAMEAGCC (Gulf Corporation
Council)Others
Make an Inquiry Before Buying
6
Global Oncology/Cancer Drugs Market Market by
Manufacturers, Regions, Type and Application,
Forecast to 2021
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
Global Oncology/Cancer Drugs Market Market by
Manufacturers, Regions, Type and Application,
Forecast to 2021 and future opportunities are
provided in the report.
Contact 1-302-261-5343 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of Sodium Percarbonate
Market Report